Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,430Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Jinarc/Jynarque

02 3Jynarque/Jinarc

03 8Samsca

04 2Samsca/Jinarc

05 1Tolvaptan Otsuka

PharmaCompass

01

Brand Name : Jinarc/Jynarque

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Jinarc/Jynarque

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 759

2019 Revenue in Millions : 544

Growth (%) : 40

blank

02

Brand Name : Samsca

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Samsca

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 838

2019 Revenue in Millions : 870

Growth (%) : -4

blank

03

Brand Name : Jinarc/Jynarque

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Jinarc/Jynarque

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 848

2020 Revenue in Millions : 728

Growth (%) : 26

blank

04

Brand Name : Samsca

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Samsca

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 777

2020 Revenue in Millions : 804

Growth (%) : 4

blank

05

Brand Name : Jynarque/Jinarc

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Jynarque/Jinarc

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 1,054

2021 Revenue in Millions : 848

Growth (%) : 24

blank

06

Brand Name : Samsca

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Samsca

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 664

2021 Revenue in Millions : 777

Growth (%) : -15

blank

07

Brand Name : Jynarque/Jinarc

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Jynarque/Jinarc

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 1,224

2022 Revenue in Millions : 1,054

Growth (%) : 32

blank

08

Brand Name : Samsca

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Samsca

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 321

2022 Revenue in Millions : 664

Growth (%) : -45

blank

09

Brand Name : Jynarque/Jinarc

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Jynarque/Jinarc

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 1,570

2023 Revenue in Millions : 1,224

Growth (%) : 28

blank

10

Brand Name : Samsca

Tolvaptan

arrow
IOPC
Not Confirmed

Brand Name : Samsca

arrow
IOPC
Not Confirmed

Tolvaptan

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 262

2023 Revenue in Millions : 321

Growth (%) : -19

blank